Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Omega-3 Supplementation for Pediatric Migraine [NA]

View source ↗

Summary

A pediatric migraine trial is evaluating omega-3 fatty acid supplementation and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 Fatty Acid Supplement (omega-3 fatty acids)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Migraine | NA | Status: ACTIVE_NOT_RECRUITING